BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15542371)

  • 1. A structure-based approach for prediction of MHC-binding peptides.
    Altuvia Y; Margalit H
    Methods; 2004 Dec; 34(4):454-9. PubMed ID: 15542371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting peptide binding to Major Histocompatibility Complex molecules.
    Liao WW; Arthur JW
    Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranking potential binding peptides to MHC molecules by a computational threading approach.
    Altuvia Y; Schueler O; Margalit H
    J Mol Biol; 1995 Jun; 249(2):244-50. PubMed ID: 7540211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from MHC-bound peptides.
    Margalit H; Altuvia Y
    Novartis Found Symp; 2003; 254():77-90; discussion 91-101, 216-22, 250-2. PubMed ID: 14712933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
    Tung CW; Ho SY
    Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules.
    Gomez-Nunez M; Pinilla-Ibarz J; Dao T; May RJ; Pao M; Jaggi JS; Scheinberg DA
    Leuk Res; 2006 Oct; 30(10):1293-8. PubMed ID: 16533527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate epitope identification using peptide property models: application to cancer immunotherapy.
    Sung MH; Simon R
    Methods; 2004 Dec; 34(4):460-7. PubMed ID: 15542372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.
    Poenaru S; Lamas JR; Folkers G; López de Castro JA; Seebach D; Rognan D
    J Med Chem; 1999 Jul; 42(13):2318-31. PubMed ID: 10395472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.
    Bian H; Hammer J
    Methods; 2004 Dec; 34(4):468-75. PubMed ID: 15542373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods and protocols for prediction of immunogenic epitopes.
    Tong JC; Tan TW; Ranganathan S
    Brief Bioinform; 2007 Mar; 8(2):96-108. PubMed ID: 17077136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide length-based prediction of peptide-MHC class II binding.
    Chang ST; Ghosh D; Kirschner DE; Linderman JJ
    Bioinformatics; 2006 Nov; 22(22):2761-7. PubMed ID: 17000752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational methods for prediction of T-cell epitopes--a framework for modelling, testing, and applications.
    Brusic V; Bajic VB; Petrovsky N
    Methods; 2004 Dec; 34(4):436-43. PubMed ID: 15542369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing the modular MHC model for predicting peptide binding.
    DeLuca DS; Blasczyk R
    Methods Mol Biol; 2007; 409():261-71. PubMed ID: 18450006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design.
    Halling-Brown M; Shaban R; Frampton D; Sansom CE; Davies M; Flower D; Duffield M; Titball RW; Brusic V; Moss DS
    Mol Immunol; 2009 Aug; 46(13):2699-705. PubMed ID: 19560824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural prediction of peptides bound to MHC class I.
    Fagerberg T; Cerottini JC; Michielin O
    J Mol Biol; 2006 Feb; 356(2):521-46. PubMed ID: 16368108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of peptide-MHC binding using profiles.
    Reche PA; Reinherz EL
    Methods Mol Biol; 2007; 409():185-200. PubMed ID: 18450001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach.
    Christensen JK; Lamberth K; Nielsen M; Lundegaard C; Worning P; Lauemøller SL; Buus S; Brunak S; Lund O
    Neural Comput; 2003 Dec; 15(12):2931-42. PubMed ID: 14629874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.